© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 13, 1032,
July 5, 2000
© 2000 Oxford University Press
NEWS |
Medicare to Cover Routine Care Costs In Clinical Trials
After years of debate and failed legislation, President Clinton issued an executive memorandum last month directing the Medicare program to reimburse health care providers for the routine costs of patient care associated with participation in all clinical trials.
The action, which went into effect immediately, is a sweet victory for those who have rallied for more than a decade to get the government to take
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. J. Sherman, D. M. Rubin, E. Venkatraman, G. K. Schwartz, V. A. Miller, M. H. Radzyner, H. S. Ruchlin, D. Spriggs, and D. G. Pfister Using Patients As Their Own Controls for Cost Evaluation of Phase I Clinical Trials J. Clin. Oncol., April 1, 2004; 22(7): 1308 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Hillner Trends in Clinical Trials Reports in Common Cancers Between 1989 and 2000 J. Clin. Oncol., May 1, 2003; 21(9): 1850 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Roche, N. Paul, B. Smuck, M. Whitehead, B. Zee, J. Pater, M.-A. Hiatt, and H. Walker Factors Affecting Workload of Cancer Clinical Trials: Results of a Multicenter Study of the National Cancer Institute of Canada Clinical Trials Group J. Clin. Oncol., January 15, 2002; 20(2): 545 - 556. [Abstract] [Full Text] [PDF] |
||||
